X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (365) 365
Publication (28) 28
Book Chapter (6) 6
Book / eBook (3) 3
Book Review (2) 2
Conference Proceeding (1) 1
Magazine Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (202) 202
male (132) 132
female (130) 130
cardiac & cardiovascular systems (120) 120
index medicus (120) 120
aged (111) 111
middle aged (111) 111
mortality (76) 76
treatment outcome (64) 64
abridged index medicus (61) 61
risk factors (53) 53
heart attacks (51) 51
medicine, general & internal (48) 48
care and treatment (46) 46
heart failure (46) 46
coronary heart disease (44) 44
drug therapy (41) 41
clinical trials (40) 40
cardiovascular disease (37) 37
myocardial infarction (37) 37
prospective studies (37) 37
cardiovascular (36) 36
follow-up studies (35) 35
prognosis (35) 35
cardiac patients (34) 34
myocardial-infarction (31) 31
randomized controlled trials as topic (30) 30
surgery (30) 30
coronary artery bypass (28) 28
myocardial infarction - drug therapy (27) 27
risk (27) 27
survival (27) 27
time factors (27) 27
acute coronary syndromes (26) 26
analysis (26) 26
cardiology (26) 26
outcomes (26) 26
cardiovascular diseases (25) 25
double-blind method (25) 25
management (24) 24
metaanalysis (24) 24
risk assessment (24) 24
aged, 80 and over (23) 23
heart failure - drug therapy (23) 23
therapy (23) 23
electrocardiography (22) 22
heart attack (22) 22
internal medicine (22) 22
percutaneous coronary intervention (22) 22
peripheral vascular disease (22) 22
myocardial infarction - mortality (21) 21
research (21) 21
unstable angina (21) 21
health aspects (20) 20
stroke (20) 20
angioplasty (19) 19
aspirin (19) 19
coronary artery disease (19) 19
patients (19) 19
adrenergic beta-antagonists - therapeutic use (18) 18
coronary vessels (18) 18
nebivolol (18) 18
platelet aggregation inhibitors - therapeutic use (18) 18
usage (18) 18
acute myocardial-infarction (17) 17
clopidogrel (17) 17
coronary angiography (17) 17
patient outcomes (17) 17
angina pectoris (16) 16
biomarkers (16) 16
medical research (16) 16
myocardial infarction - prevention & control (16) 16
stents (16) 16
trial (16) 16
adult (15) 15
disease (15) 15
heart (15) 15
heart failure - mortality (15) 15
ischemia (15) 15
medicine (15) 15
randomized-trial (15) 15
registries (15) 15
studies (15) 15
cardiology and cardiovascular medicine (14) 14
hemorrhage - chemically induced (14) 14
intervention (14) 14
myocardial infarction - epidemiology (14) 14
myocardial infarction - therapy (14) 14
ticlopidine - analogs & derivatives (14) 14
atherosclerosis (13) 13
clinical outcomes (13) 13
confidence intervals (13) 13
heart diseases (13) 13
hospitalization (13) 13
prevention (13) 13
revascularization (13) 13
acute coronary syndrome (12) 12
angioplasty, balloon, coronary (12) 12
c-reactive protein (12) 12
coronary artery disease - surgery (12) 12
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9745, pp. 975 - 983
Journal Article
Journal Article
2004, 1st ed. with expanded index., ISBN 9781901346657, 324
Book
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2016, Volume 67, Issue 15, pp. 1759 - 1768
Abstract Background In a prospective, multicenter, randomized controlled trial, 4,146 patients were randomized to receive standard care or standard care plus... 
Cardiovascular | Internal Medicine | invasive coronary angiography | angina pectoris | preventive therapy | myocardial infarction | CARDIAC & CARDIOVASCULAR SYSTEMS | RISK-FACTORS | MYOCARDIAL-INFARCTION | RANDOMIZED-TRIALS | CHOLESTEROL | CT ANGIOGRAPHY | SCOT-HEART | HEART-DISEASE | THERAPY | ARTERY-DISEASE | CLINICAL-OUTCOMES | Coronary Vessels - diagnostic imaging | Myocardial Infarction - mortality | Tomography, X-Ray Computed - economics | Humans | Middle Aged | Tomography, X-Ray Computed - methods | Male | Secondary Prevention - methods | Comparative Effectiveness Research | Coronary Angiography - methods | Coronary Angiography - economics | Clinical Decision-Making | Female | Coronary Angiography - statistics & numerical data | Myocardial Infarction - etiology | Severity of Illness Index | Mortality | Secondary Prevention - statistics & numerical data | Outcome and Process Assessment (Health Care) | Tomography, X-Ray Computed - statistics & numerical data | Coronary Artery Disease - therapy | Coronary Artery Disease - diagnosis | Coronary Artery Disease - complications | Aged | Myocardial Infarction - prevention & control | Medical equipment | Medical colleges | CT imaging | Care and treatment | Angiography | Cardiac patients | Coronary heart disease | Physiological apparatus | Usage | Medicine, Preventive | Preventive health services | Cardiovascular disease | Heart attacks | Medical imaging | Angina pectoris | Clinical outcomes | HR, hazard ratio | IQR, interquartile range | OR, odds ratio | Original Investigation | CCTA, coronary computed tomography angiography
Journal Article
Lancet, The, ISSN 0140-6736, 2009, Volume 373, Issue 9670, pp. 1190 - 1197
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2007, Volume 49, Issue 19, pp. 1982 - 1988
Journal Article
Lancet, The, ISSN 0140-6736, 2008, Volume 371, Issue 9612, pp. 559 - 568
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2017, Volume 377, Issue 12, pp. 1119 - 1131
Patients with myocardial infarction and a high-sensitivity CRP level of 2 mg or more per liter were assigned to one of three canakinumab doses or placebo. The... 
C-REACTIVE PROTEIN | MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | MYOCARDIAL-INFARCTION | STATIN THERAPY | CLONAL HEMATOPOIESIS | INFLAMMATION | CARDIOVASCULAR-DISEASE | INTERLEUKIN-1-BETA INHIBITION | RISK | CORONARY-ARTERY-DISEASE | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Male | Secondary Prevention | Infection - etiology | Incidence | Dose-Response Relationship, Drug | Anti-Inflammatory Agents - adverse effects | C-Reactive Protein - metabolism | Lipids - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Anti-Inflammatory Agents - administration & dosage | Female | Neutropenia - chemically induced | Interleukin-1beta - antagonists & inhibitors | Stroke - prevention & control | Atherosclerosis - drug therapy | Double-Blind Method | Interleukin-1beta - immunology | Atherosclerosis - blood | Myocardial Infarction - drug therapy | Antibodies, Monoclonal - administration & dosage | Aged | Myocardial Infarction - prevention & control | Myocardial infarction | Cerebral infarction | Stroke | Heart attacks | C-reactive protein | Cytokines | Clinical trials | Cardiovascular disease | Innate immunity | Inflammation | Angina | Angina pectoris | Thrombosis | Cholesterol | Disease prevention | Proteins | Arteriosclerosis | Atherosclerosis | Cardiovascular diseases | Health risk assessment | Drug therapy | Drug dosages | Klinisk medicin | Clinical Medicine
Journal Article